Mark Nawacki
Fortune : 292 000 $ au 31/05/2026
Fortune : 292 000 $ au 31/05/2026
Mark H.
Nawacki is the founder of Searchlight Pharma, Inc., founded in 2015, where the title held is President.
Current jobs include Director at IntelGenx Corp., Director at Festival Bach Montreal, Director at Sacred Heart School of Montreal, Director at Montreal Bach Festival, and Director at Satellos Bioscience, Inc. starting in 2025.
Former jobs include Chairman at Kane Biotech, Inc. from 2021 to 2023, President & Director at Canadian Healthcare Licensing Association, Non-Executive Director at Litha Healthcare Group Ltd. from 2012 to 2014, Independent Director at IntelGenx Technologies Corp.
from 2016 to 2024, Vice President-Corporate & Business Development at Paladin Labs, Inc. from 2012 to 2014, and Trustee at Licensing Executives Society.
Education includes undergraduate and MBAistration degrees from the University of Toronto.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SATELLOS BIOSCIENCE INC 0,19 % | 18/06/2026 | 40 000 ( 0,19 % ) | 292 000 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SATELLOS BIOSCIENCE INC. | Directeur/Membre du Conseil | 14/11/2025 |
Searchlight Pharma, Inc.
Searchlight Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Fondateur | 01/01/2015 |
Festival Bach Montreal | Directeur/Membre du Conseil | - |
Sacred Heart School of Montreal | Directeur/Membre du Conseil | - |
Montreal Bach Festival | Directeur/Membre du Conseil | - |
Intelgenx Corp.
Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Develops oral-controlled release pharmaceutical products | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| INTELGENX TECHNOLOGIES CORP. | Directeur/Membre du Conseil | 02/10/2024 |
| KANE BIOTECH INC. | Président | 01/03/2023 |
| LITHA HEALTHCARE GROUP LIMITED | Directeur/Membre du Conseil | 10/10/2014 |
| ░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 13 |
|---|---|
Paladin Labs, Inc.
Paladin Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceuticals | Health Technology |
Kane Biotech, Inc.
Kane Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that manufactures animal health oral care products | Commercial Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intelgenx Corp.
Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Develops oral-controlled release pharmaceutical products | Health Technology |
IntelGenx Technologies Corp.
IntelGenx Technologies Corp. Pharmaceuticals: MajorHealth Technology Operates as a drug delivery company that develops and manufactures oral film therapeutics | Health Technology |
Licensing Executives Society
Licensing Executives Society Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization that provides world leading events, useful resources and publications for deal-making, education and best practices | Commercial Services |
Canadian Healthcare Licensing Association | |
Litha Healthcare Group Ltd.
Litha Healthcare Group Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Searchlight Pharma, Inc.
Searchlight Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Festival Bach Montreal | |
Sacred Heart School of Montreal | |
Montreal Bach Festival | |
Satellos Bioscience, Inc.
Satellos Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company, which is focused on the identification, development and commercialization of drug candidates | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national